Trials / Conditions / Liver Fibrosis Due to NASH
Liver Fibrosis Due to NASH
3 registered clinical trials studyying Liver Fibrosis Due to NASH — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and S NCT06797596 | Fibronostics USA, Inc | — |
| Terminated | Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Seco NCT01672866 | Gilead Sciences | Phase 2 |
| Terminated | Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH NCT01672879 | Gilead Sciences | Phase 2 |